LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

BIOTECON Expedites Launch of Viral RNA Extraction Kit for Detecting COVID-19

By LabMedica International staff writers
Posted on 06 Apr 2020
Image: Biotecon Diagnostics Acu-Corona COVID-19 Detection Kits (Photo courtesy of BIOTECON Diagnostics GmbH)
Image: Biotecon Diagnostics Acu-Corona COVID-19 Detection Kits (Photo courtesy of BIOTECON Diagnostics GmbH)
BIOTECON Diagnostics GmbH (Potsdam, Germany) has launched its newly-developed foodproof Magnetic Preparation Kit VI, which enables lab specialists to perform rapid, sensitive, and reliable RNA and DNA extraction from an array of different viruses. The kit is a welcome solution for high volume, rapid RNA/DNA extraction from all kinds of viruses to increase testing capacity and will support the urgent need for lab testing during the COVID-19 global pandemic.

BIOTECON focuses on the development, production and international marketing of real-time PCR-based, rapid detection technologies, including sample preparation and DNA extraction. BIOTECON’s foodproof Magnetic Preparation Kit VI is based on magnetic bead technology, in which full sample preparation with lysis, extraction, and purification is carried out fully automatically. The key pathogen components are bound to magnetic particles and passed through various washing steps. Time-consuming manual steps, such as external sample preparation, which could also pose a risk of contamination, are no longer necessary due to the integrated enzymatic lysis. The highly purified RNA or DNA is eluted in an appropriate elution buffer, which is then ready to be used in PCR detection kits. The kit contains all required reagents, including enzyme, buffer, and carrier tRNA for the lysis step, as well as the magnetic beads to carry out extraction from complex matrices.

Additionally, BIOTECON has partnered with a Singaporean company to distribute Acu-Corona 2.0/3.0 Kits, which are real-time PCR assays for the detection of SARS-CoV-2 extracted from patient samples. Patients whether suspected to be infected with the virus or not may provide oral or nasal swabs, which are then used as samples for viral RNA extraction and subsequent real-time PCR.

"Our collaboration has vastly accelerated the availability of this rapid, high-throughput assay that is easy-to-use, reliable, cost-effective and allows up to 94 patient samples per 1.5 hours. As a key player in the field of real-time PCR diagnostics, we have responded to the global pandemic by launching our Magnetic Preparation Kit VI for viral RNA extraction and purification. Our kit works hand-in-hand with this real-time PCR assay to accurately detect the SARS-CoV-2 virus and therefore support mass diagnostic efforts," said Alois Schneiderbauer, the Chief Business Officer of BIOTECON Diagnostics.

Related Links:
BIOTECON Diagnostics GmbH

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Human Estradiol Assay
Human Estradiol CLIA Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more